Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages

CC. Dos Santos, KV. Walburg, S. van Veen, LG. Wilson, CEM. Trufen, IP. Nascimento, THM. Ottenhoff, LCC. Leite, MC. Haks

. 2022 ; 10 (6) : . [pub] 20220524

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22017103

Grantová podpora
2017/03332-5 São Paulo Research Foundation
2014/01271-0 São Paulo Research Foundation
2017/24832-6 São Paulo Research Foundation

Tuberculosis (TB) is one of the top 10 leading causes of death worldwide. The recombinant BCG strain expressing the genetically detoxified A subunit of the thermolabile toxin from Escherichia coli (LTAK63) adjuvant (rBCG-LTAK63) has previously been shown to confer superior protection and immunogenicity compared to BCG in a murine TB infection model. To further investigate the immunological mechanisms induced by rBCG-LTAK63, we evaluated the immune responses induced by rBCG-LTAK63, BCG, and Mycobacterium tuberculosis (Mtb) H37Rv strains in experimental infections of primary human M1 and M2 macrophages at the transcriptomic and cytokine secretion levels. The rBCG-LTAK63-infected M1 macrophages more profoundly upregulated interferon-inducible genes such as IFIT3, OAS3, and antimicrobial gene CXCL9 compared to BCG, and induced higher levels of inflammatory cytokines such as IL-12(p70), TNF-β, and IL-15. The rBCG-LTAK63-infected M2 macrophages more extensively upregulated transcripts of inflammation-related genes, TAP1, GBP1, SLAMF7, TNIP1, and IL6, and induced higher levels of cytokines related to inflammation and tissue repair, MCP-3 and EGF, as compared to BCG. Thus, our data revealed an important signature of immune responses induced in human macrophages by rBCG-LTAK63 associated with increased inflammation, activation, and tissue repair, which may be correlated with a protective immune response against TB.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017103
003      
CZ-PrNML
005      
20220720100112.0
007      
ta
008      
220718s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/vaccines10060831 $2 doi
035    __
$a (PubMed)35746439
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Dos Santos, Carina C $u Laboratório de Desenvolvimento de Vacinas, Instituto Butantan, São Paulo 05503-900, Brazil $u Programa de Pós-Graduação Interunidades em Biotecnologia, Universidade de São Paulo, São Paulo 05508-900, Brazil $u Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands $u Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Federal University of Bahia, Salvador 40170-115, Brazil $1 https://orcid.org/0000000228980851
245    10
$a Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages / $c CC. Dos Santos, KV. Walburg, S. van Veen, LG. Wilson, CEM. Trufen, IP. Nascimento, THM. Ottenhoff, LCC. Leite, MC. Haks
520    9_
$a Tuberculosis (TB) is one of the top 10 leading causes of death worldwide. The recombinant BCG strain expressing the genetically detoxified A subunit of the thermolabile toxin from Escherichia coli (LTAK63) adjuvant (rBCG-LTAK63) has previously been shown to confer superior protection and immunogenicity compared to BCG in a murine TB infection model. To further investigate the immunological mechanisms induced by rBCG-LTAK63, we evaluated the immune responses induced by rBCG-LTAK63, BCG, and Mycobacterium tuberculosis (Mtb) H37Rv strains in experimental infections of primary human M1 and M2 macrophages at the transcriptomic and cytokine secretion levels. The rBCG-LTAK63-infected M1 macrophages more profoundly upregulated interferon-inducible genes such as IFIT3, OAS3, and antimicrobial gene CXCL9 compared to BCG, and induced higher levels of inflammatory cytokines such as IL-12(p70), TNF-β, and IL-15. The rBCG-LTAK63-infected M2 macrophages more extensively upregulated transcripts of inflammation-related genes, TAP1, GBP1, SLAMF7, TNIP1, and IL6, and induced higher levels of cytokines related to inflammation and tissue repair, MCP-3 and EGF, as compared to BCG. Thus, our data revealed an important signature of immune responses induced in human macrophages by rBCG-LTAK63 associated with increased inflammation, activation, and tissue repair, which may be correlated with a protective immune response against TB.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Walburg, Kimberley V $u Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
700    1_
$a van Veen, Suzanne $u Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
700    1_
$a Wilson, Louis G $u Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
700    1_
$a Trufen, Carlos E M $u Czech Centre for Phenogenomics, 25250 Vestec, Czech Republic $1 https://orcid.org/0000000312160418
700    1_
$a Nascimento, Ivan P $u Laboratório de Desenvolvimento de Vacinas, Instituto Butantan, São Paulo 05503-900, Brazil
700    1_
$a Ottenhoff, Tom H M $u Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
700    1_
$a Leite, Luciana C C $u Laboratório de Desenvolvimento de Vacinas, Instituto Butantan, São Paulo 05503-900, Brazil $u Programa de Pós-Graduação Interunidades em Biotecnologia, Universidade de São Paulo, São Paulo 05508-900, Brazil
700    1_
$a Haks, Mariëlle C $u Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
773    0_
$w MED00200686 $t Vaccines $x 2076-393X $g Roč. 10, č. 6 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35746439 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100107 $b ABA008
999    __
$a ind $b bmc $g 1816439 $s 1168345
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 10 $c 6 $e 20220524 $i 2076-393X $m Vaccines $n Vaccines (Basel) $x MED00200686
GRA    __
$a 2017/03332-5 $p São Paulo Research Foundation
GRA    __
$a 2014/01271-0 $p São Paulo Research Foundation
GRA    __
$a 2017/24832-6 $p São Paulo Research Foundation
LZP    __
$a Pubmed-20220718

Najít záznam

Citační ukazatele

Možnosti archivace